These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37749657)

  • 1. Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series.
    Rasner CJ; Schultz B; Bohjanen K; Pearson DR
    J Med Case Rep; 2023 Sep; 17(1):408. PubMed ID: 37749657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
    Zhang JL; Wang SH; Cui SN; Zhang J; Li SZ; Li L; Zuo YG
    J Dermatol; 2023 Nov; 50(11):1433-1441. PubMed ID: 37501390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
    Korman NJ; Stanley JR; Woodley DT
    Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune bullous skin diseases].
    Joly P
    Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
    Alpsoy E; Akman-Karakas A; Uzun S
    Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Status of Patients with Autoimmune Bullous Diseases (Pemphigus and Bullous Pemphigoids) in Dermatology Clinics of Mashhad University of Medical Sciences During the COVID-19 Pandemic Using Telemedicine.
    Mehri Z; Nahidi Y; Ramezani B; Torabi S
    Telemed J E Health; 2024 Jun; 30(6):e1742-e1746. PubMed ID: 38416427
    [No Abstract]   [Full Text] [Related]  

  • 10. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
    Akoglu G
    Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and autoimmune bullous diseases: Lessons learned.
    Kasperkiewicz M; Woodley DT
    Autoimmun Rev; 2023 Apr; 22(4):103286. PubMed ID: 36738951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?
    Damiani G; Pacifico A; Pelloni F; Iorizzo M
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e645-e647. PubMed ID: 34169578
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Skin Conditions: Autoimmune Blistering Disease.
    Helm M; Helm LA; Clebak KT; Foulke G
    FP Essent; 2023 Mar; 526():13-17. PubMed ID: 36913658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous Pemphigoid After Vaccination With the Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: Two Cases in China.
    Guo Z; Wang Y; Tang H; Fan M; Wang W; Ding Y; Shen S; Zhou W; Zhang Y; Wang Z
    Wound Manag Prev; 2022 Nov; 68(11):22-25. PubMed ID: 36493373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus.
    Bălăceanu-Gurău B; Dumitrascu A; Giurcăneanu C; Tatar R; Gurău CD; Orzan OA
    Vaccines (Basel); 2024 Jul; 12(8):. PubMed ID: 39203983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study.
    Tan AJ; Archila M; Barbieri JS; Mostaghimi A; Scherer AM; Perez-Chada LM; Asgari MM; Gelfand JM; Noe MH
    Arch Dermatol Res; 2024 Apr; 316(5):125. PubMed ID: 38637431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
    Fitzpatrick S; Cha S; Katz J; Migliorati C
    Quintessence Int; 2024 May; 55(5):400-411. PubMed ID: 38415994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset.
    Russo R; Gasparini G; Cozzani E; D'Agostino F; Parodi A
    Front Immunol; 2022; 13():834316. PubMed ID: 35251024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.